APA (7th ed.) Citation

Möbus, V., Lück, H., Ladda, E., Klare, P., Schmidt, M., Schneeweiss, A., . . . Loibl, S. (2021). Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2). European journal of cancer, 156, . https://doi.org/10.1016/j.ejca.2021.07.033

Chicago Style (17th ed.) Citation

Möbus, Volker, et al. "Phase III Randomised Trial Comparing Intense Dose-dense Chemotherapy to Tailored Dose-dense Chemotherapy in High-risk Early Breast Cancer (GAIN-2)." European Journal of Cancer 156 (2021). https://doi.org/10.1016/j.ejca.2021.07.033.

MLA (9th ed.) Citation

Möbus, Volker, et al. "Phase III Randomised Trial Comparing Intense Dose-dense Chemotherapy to Tailored Dose-dense Chemotherapy in High-risk Early Breast Cancer (GAIN-2)." European Journal of Cancer, vol. 156, 2021, https://doi.org/10.1016/j.ejca.2021.07.033.